UW-Madison suffered a setback Friday in its drawn-out and complicated battle to maintain three of its valuable stem-cell patents.
The U.S. Patent and Trademark Office indicated it is skeptical of the patents, which cover techniques for isolating embryonic stem cells.
But the case is hardly over.